Half-year report · HY
2931.TEDINET S100YVGZ
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥50.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥909m | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥73m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥805m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥559m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥888m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥133m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥69.3bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥72.3bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥69.1bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.7bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.8bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.6bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥28.5bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥31.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.2bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥674m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥585m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥514m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.9bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥0.53 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.9 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.1 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥0.52 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.8% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥4m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥805m |
| Biofuel Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥764m |
| Biofuel Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥160m |
| Health Care Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥24.3bn |
| Health Care Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥3.0bn |
| Others Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Others Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥202m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥26.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥4m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥8m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥790m |
| Biofuel Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥457m |
| Biofuel Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥114m |
| Health Care Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥22.7bn |
| Health Care Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥0 |
| Health Care Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.8bn |
| Others Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Others Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥7m |
| Others Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥218m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥24.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥8m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 632
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 24553000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | 7000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 8000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -8000000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 22671000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | 457000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | 1432000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 24562000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -8000000 | JPY |
| Net sales | Prior1InterimDuration | 24553000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 2760000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | -114000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | -218000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2427000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -790000000 | JPY |
| Operating income | Prior1InterimDuration | 1636000000 | JPY |
| Direct sales | InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 17652000000 | JPY |
| Direct sales | InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Direct sales | InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Direct sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 17652000000 | JPY |
| Direct sales | InterimDuration_ReconcilingItemsMember | － | JPY |
| Direct sales | InterimDuration | 17652000000 | JPY |
| Distribution | InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 2035000000 | JPY |
| Distribution | InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Distribution | InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Distribution | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2035000000 | JPY |
| Distribution | InterimDuration_ReconcilingItemsMember | － | JPY |
| Distribution | InterimDuration | 2035000000 | JPY |
| Original equipment manufacturing material overseas | InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 4604000000 | JPY |
| Original equipment manufacturing material overseas | InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 4604000000 | JPY |
| Original equipment manufacturing material overseas | InterimDuration_ReconcilingItemsMember | － | JPY |
| Original equipment manufacturing material overseas | InterimDuration | 4604000000 | JPY |
| Others | InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 25000000 | JPY |
| Others | InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | 764000000 | JPY |
| Others | InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | 1423000000 | JPY |
| Others | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 2213000000 | JPY |
| Others | InterimDuration_ReconcilingItemsMember | － | JPY |
| Others | InterimDuration | 2213000000 | JPY |
| Revenue from contracts with customers | InterimDuration_jpcrp040300-ssr_E27054-000HealthCareBusinessReportableSegmentsMember | 24319000000 | JPY |
| Revenue from contracts with customers | InterimDuration_jpcrp040300-ssr_E27054-000BiofuelBusinessReportableSegmentsMember | 764000000 | JPY |
| Revenue from contracts with customers | InterimDuration_jpcrp040300-ssr_E27054-000OthersBusinessReportableSegmentsMember | 1423000000 | JPY |
| Revenue from contracts with customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 26507000000 | JPY |
| Revenue from contracts with customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenue from contracts with customers | InterimDuration | 26507000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |